Concor 5 (Bisoprolol): Slowing High Heart Rate, Palpitations & Beta-Blocker Rules
Clinical review of Concor 5 (Bisoprolol Fumarate): selective beta-1 blocker, resting tachycardia, heart failure protection, and never stopping abruptly.
Concor 5 contains Bisoprolol Fumarate (5mg), a highly cardioselective beta-1 adrenergic blocker. It blocks adrenaline from stimulating the heart, lowering elevated resting heart rates, soothing palpitations, and reducing cardiac oxygen demand in coronary artery disease and heart failure.
1. Cardioselective Beta-1 Inhibition
Unlike non-selective beta-blockers like Propranolol that can trigger bronchospasm in the lungs, Bisoprolol selectively targets beta-1 receptors on the heart muscle and sinoatrial node, safely controlling pulse with minimal pulmonary airway effects.
2. The Critical Rebound Tachycardia Hazard
Never stop taking Concor abruptly. Sudden withdrawal leaves cardiac beta receptors hypersensitive to circulating adrenaline, which can provoke severe rebound tachycardia, dangerous arrhythmias, or acute angina attacks. Always taper under medical supervision.
3. Generic Pricing
Branded Concor 5 costs ~₹135 for 10 tablets. Jan Aushadhi generic Bisoprolol 5mg tablets cost ₹15.00 for 10 tablets (88% savings).
Top 8 Essential Indian Medicines: Branded MRP vs. Jan Aushadhi Generic Comparison
Compare average Indian retail MRP of top branded formulations against government-certified PMBJP Jan Aushadhi bioequivalent generic prices and active salts. Verified against official PMBJP formularies, NPPA price caps, and CDSCO regulatory registries.
| Brand Name | Leading Manufacturer | Active Salt Formulation (IP) | Branded MRP | Jan Aushadhi Price | Savings % |
|---|---|---|---|---|---|
| Augmentin 625 Duo | GlaxoSmithKline Pharmaceuticals | Amoxicillin Trihydrate 500mg + Potassium Clavulanate 125mg IP | ₹220.00 | ₹58.00 | 74% |
| Dolo 650 | Micro Labs Ltd | Paracetamol (Acetaminophen) 650mg IP | ₹34.00 | ₹5.50 | 84% |
| Pantocid 40 | Sun Pharmaceutical Industries | Pantoprazole Sodium 40mg IP (Gastro-resistant) | ₹155.00 | ₹8.00 | 95% |
| Azithral 500 | Alembic Pharmaceuticals | Azithromycin Dihydrate 500mg IP | ₹132.00 | ₹24.00 | 82% |
| Glycomet 500 | USV Private Limited | Metformin Hydrochloride 500mg IP | ₹24.00 | ₹4.50 | 81% |
| Shelcal 500 | Torrent Pharmaceuticals | Elemental Calcium 500mg + Cholecalciferol (Vit D3) 250 IU IP | ₹134.00 | ₹16.00 | 88% |
| Telma 40 | Glenmark Pharmaceuticals | Telmisartan 40mg IP | ₹92.00 | ₹7.50 | 92% |
| Montair-LC | Cipla Ltd | Montelukast Sodium 10mg + Levocetirizine Dihydrochloride 5mg IP | ₹210.00 | ₹18.00 | 91% |
| Combined 8-Drug Essential Therapy Basket Total: | ₹1,001.00 | ₹141.00 | 85.9% Net Savings | ||
Frequently Asked Questions (Clinical & Regulatory)
Q1: What is the target resting heart rate while taking Concor?
Cardiologists typically target a resting pulse between 60 and 70 beats per minute in patients on beta-blocker therapy.
Q2: Can Concor cause fatigue or cold hands and feet?
Yes, reduced peripheral blood circulation and lower pulse rate can temporarily cause mild lethargy and cold extremities when starting therapy.
Q3: What is the clinical danger of abruptly stopping blood pressure medications like Telmisartan or Amlodipine?
Sudden discontinuation of antihypertensives can precipitate acute rebound hypertension, hypertensive encephalopathy, acute coronary syndrome, or cerebrovascular accident. Dose titrations must always be conducted under structured clinical supervision.
Q4: Are Jan Aushadhi generic cardiovascular medicines bioequivalent to branded drugs like Telma 40?
Yes. Jan Aushadhi Telmisartan 40mg and Amlodipine 5mg tablets satisfy CDSCO dissolution, content uniformity, and bioavailability requirements, costing ₹7.50 compared to ₹92.00 for branded retail packages.
Q5: Why are ACE inhibitors and Angiotensin Receptor Blockers (ARBs) contraindicated in pregnancy?
Telmisartan, Losartan, and Enalapril are fetotoxic, causing fetal renal dysgenesis, oligohydramnios, neonatal anuria, and calvarial hypoplasia when administered during the second and third trimesters of pregnancy.
This clinical guide is authored and reviewed in accordance with the regulatory standards of the Indian Pharmacopoeia (IP), Central Drugs Standard Control Organization (CDSCO) drug schedules, and Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) bioequivalence guidelines. All therapeutic recommendations and drug interaction warnings are cross-referenced with official statutory publications.
Under India's Digital Personal Data Protection (DPDP) Act, 2023, MediMatch AI functions as a data fiduciary committed to zero retention of private health identifiers. Browsing educational guides, reviewing active salt monographs, and executing search queries occur without tracking or commercial profiling. All client interactions with prescription readers or lab decoders execute ephemerally in volatile memory with zero server-side storage of protected health information (PHI). For inquiries regarding data fiduciary obligations, contact our Data Protection Officer at privacy@medimatchai.in.